COVID: Phase 1 pharmacokinetic profile supports the potential for ratutrelvir to be dosed as a once-a-day, single drug, 10-day treatment course, ...
BOTHELL, Wash., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) reports financial results for the three and nine months ended September 30, 2024, ...
Hosted on MSN16h
Ozempic and Viagra, among the more than 80 drugs expected to work against Alzheimer's in the coming yearsAmong the list of drugs in development for Alzheimer's compiled by Phrma, there is an interesting proposal, the protease ...
The Inhibition of Metallo Protease by BMS-186716 in a Randomized ... occurrence of severe angioedema was higher than with any ACE inhibitors, and BMS was instructed to find a way around this ...
In this note, we will discuss the latest decisions on the merits from the Dutch patent court on the matter of plausibility and inventive step.
Aigen Investment Management LP raised its position in shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Free Report) by ...
Patient dosing has begun in a phase 1 trial evaluating QXL138AM, a masked immunocytokine targeting CD138, in advanced solid ...
Clinical Assessment Is Being Performed on a Pediatric Patient at Children’s Health Ireland in Dublin First Evaluation of ...
Laboratory of Chemical Biology, Department of Cellular and Molecular Medicine, KU Leuven − University of Leuven, Herestraat 49 box 901b, 3000 Leuven, Belgium ...
plus complete proteases inhibitors (Merck KGaA, Darmstadt, Germany) at different time points (0, 3, 6 h) (Tomati et al., 2018). Lysates were separated by centrifugation (15,000 x g at 4°C for 10 min) ...
This study presents important findings on cold tolerance shared between hibernating and non-hibernating mammals, identifying a key molecule, GPX4, through multi-species genome-wide CRISPR screens. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback